DekaBank Deutsche Girozentrale’s IDEAYA Biosciences IDYA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Hold	50,000	–	–	﹤0.01%	723
2026 Q1	$1.68M	Hold	50,000	–	–	﹤0.01%	723
2025 Q4	$2.35M	Hold	50,000	–	–	﹤0.01%	738
2025 Q3	$1.35M	Hold	50,000	–	–	﹤0.01%	821
2025 Q2	$1.07M	Hold	50,000	–	–	﹤0.01%	854
2025 Q1	$843K	Hold	50,000	–	–	﹤0.01%	878
2024 Q4	$1.28M	Hold	50,000	–	–	﹤0.01%	827
2024 Q3	$1.53M	Hold	50,000	–	–	﹤0.01%	810
2024 Q2	$1.72M	Hold	50,000	–	–	﹤0.01%	789
2024 Q1	$2.13M	Hold	50,000	–	–	﹤0.01%	743
2023 Q4	$1.76M	Hold	50,000	–	–	﹤0.01%	798
2023 Q3	$1.31M	Hold	50,000	–	–	﹤0.01%	826
2023 Q2	$1.15M	Buy	50,000 +38,700	+342%	+$796K	﹤0.01%	850
2023 Q1	$150K	Hold	11,300	–	–	﹤0.01%	1223
2022 Q4	$203K	Hold	11,300	–	–	﹤0.01%	1218
2022 Q3	$157K	Hold	11,300	–	–	﹤0.01%	1262
2022 Q2	$155K	Hold	11,300	–	–	﹤0.01%	1235
2022 Q1	$126K	Buy	11,300 +1,000	+10%	+$14.7K	﹤0.01%	1257
2021 Q4	$241K	Buy	10,300 +300	+3%	+$6.97K	﹤0.01%	1238
2021 Q3	$248K	Hold	10,000	–	–	﹤0.01%	1166
2021 Q2	$210K	Hold	10,000	–	–	﹤0.01%	1210
2021 Q1	$227K	Hold	10,000	–	–	﹤0.01%	1163
2020 Q4	$124K	Buy	+10,000	New	+$135K	﹤0.01%	1251

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DekaBank Deutsche Girozentrale's IDYA Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 50,000 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #723.

DekaBank Deutsche Girozentrale first reported a position in IDYA in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.35M in Q4 2025. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

DekaBank Deutsche Girozentrale held 50,000 shares of IDEAYA Biosciences worth $1.64M as of Q2 2026.
DekaBank Deutsche Girozentrale left its IDEAYA Biosciences share count unchanged in Q2 2026.
IDEAYA Biosciences made up ﹤0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #723 holding.
DekaBank Deutsche Girozentrale first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 23 quarters since.
DekaBank Deutsche Girozentrale's IDEAYA Biosciences position peaked at $2.35M in Q4 2025.
285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.